Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00730_DB00924_nanopub.RALXXdjSAtFewm63_K-L6mFImzC4_mWS028Y2t75TUKnU#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00730_DB00924 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00730_DB00924 label "DDI between Thiabendazole and Cyclobenzaprine - The strong CYP1A2 inhibitor, Thiabendazole, may increase the effects and toxicity of Cyclobenzaprine by decreasing Cyclobenzaprine metabolism and clearance. Monitor for changes in the therapeutic and adverse effects of Cyclobenzaprine if Thiabendazole is initiated, discontinued or dose changed. [drugbank_resource:DB00730_DB00924]" assertion.
- drugbank_resource:DB00730_DB00924 identifier "drugbank_resource:DB00730_DB00924" assertion.
- drugbank_resource:DB00730_DB00924 title "DDI between Thiabendazole and Cyclobenzaprine - The strong CYP1A2 inhibitor, Thiabendazole, may increase the effects and toxicity of Cyclobenzaprine by decreasing Cyclobenzaprine metabolism and clearance. Monitor for changes in the therapeutic and adverse effects of Cyclobenzaprine if Thiabendazole is initiated, discontinued or dose changed." assertion.
- drugbank:DB00730 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00730_DB00924 assertion.
- drugbank:DB00924 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00730_DB00924 assertion.